Clinical trial
Phase II Multicenter Clinical Trial: Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic Countries
NCT05849857 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Multicenter Clinical Trial: Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic Countries
- Lead sponsor
- Oslo University Hospital
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- September 11, 2023
- Completion date
- August 31, 2028
- Enrollment
- 80 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.